Skip to main content
. 2018 Oct 9;7(10):338. doi: 10.3390/jcm7100338

Figure 4.

Figure 4

Incidence of major bleeding and ischemic stroke/systemic emboli requiring hospitalization among patients with non-valvular atrial fibrillation receiving oral anticoagulants. Upper left: the apixaban group. Upper right: the rivaroxaban group. Lower left: the dabigatran group. Lower right: the warfarin group.